Georgiamune Inc.
Justin Fairchild is an experienced clinical development leader with extensive expertise in the biopharmaceutical industry. Currently serving as Vice President and Head of Clinical Development at Georgiamune Inc. since February 2024, Justin previously held the role of Vice President of Clinical Development at Portage Biotech Inc. from June 2022 to May 2024. Justin's experience includes serving as a Clinical Development Consultant and Vice President of Clinical Development at the Parker Institute for Cancer Immunotherapy, from October 2018 to June 2023, and various positions at Bristol-Myers Squibb, including Director of Clinical Development - Immuno-Oncology, from April 2005 to October 2018. Justin holds a Master of Public Health in Epidemiology from The Johns Hopkins University and a Bachelor of Arts in Chemistry from Colgate University.
This person is not in any teams
This person is not in any offices
Georgiamune Inc.
Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Unique approaches to re-establishing immune balance and groundbreaking scientific discoveries have led to the development of pioneering immune therapeutics for cancer and autoimmune diseases.